sb 203580 has been researched along with dihydrokainate in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (dihydrokainate) | Trials (dihydrokainate) | Recent Studies (post-2010) (dihydrokainate) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 180 | 0 | 46 |
| Protein | Taxonomy | sb 203580 (IC50) | dihydrokainate (IC50) |
|---|---|---|---|
| Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | Rattus norvegicus (Norway rat) | 14.5 | |
| Chain A, Glutamate Receptor Subunit 2 | Rattus norvegicus (Norway rat) | 14.5 | |
| Chain B, Glutamate Receptor Subunit 2 | Rattus norvegicus (Norway rat) | 14.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, SJ; Hu, YY; Li, WB; Sun, YW; Xian, XH; Zhang, JG; Zhang, LY; Zhang, M | 1 |
1 other study(ies) available for sb 203580 and dihydrokainate
| Article | Year |
|---|---|
The p38 MAPK/NF-κB pathway mediates GLT-1 up-regulation during cerebral ischemic preconditioning-induced brain ischemic tolerance in rats.
Topics: Animals; Brain Ischemia; CA1 Region, Hippocampal; Excitatory Amino Acid Transporter 2; Imidazoles; Ischemic Preconditioning; Kainic Acid; Male; MAP Kinase Signaling System; Neuroprotection; NF-kappa B; NF-kappa B p50 Subunit; Nitriles; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Wistar; Sulfones; Transcription Factor RelA | 2021 |